CH396007A - Manufacturing process for new piperazine derivatives - Google Patents

Manufacturing process for new piperazine derivatives

Info

Publication number
CH396007A
CH396007A CH683561A CH683561A CH396007A CH 396007 A CH396007 A CH 396007A CH 683561 A CH683561 A CH 683561A CH 683561 A CH683561 A CH 683561A CH 396007 A CH396007 A CH 396007A
Authority
CH
Switzerland
Prior art keywords
carbinol
phenyl
piperazine
alpha
halide
Prior art date
Application number
CH683561A
Other languages
French (fr)
Inventor
Jenni Adolphe
Rathgeb Paul
Surber Werner
Original Assignee
Pharma Yptor S A Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Yptor S A Lab filed Critical Pharma Yptor S A Lab
Priority to CH683561A priority Critical patent/CH396007A/en
Publication of CH396007A publication Critical patent/CH396007A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

  

  



  Procédé de fabrication de nouveaux dérivés de la pipérazine
 La présente invention a pour objet un   procédé    de fabrication n de nouveaux dérivés de   la. pipérazine,    correspondant à la formule :
EMI1.1     
 dans laquelle R et   R'représ, entent un groupe alcoyle,    aralcoyle ou   cyclo-alcoyE    contenant 1 à 8 atomes de carbone, R" représentant un atome halogène en position   ortho.   



   Ce procédé est caractérisé par le fait que l'on fait réagir en présence d'un agent de condensation alcalin, un carbinol de la formule
EMI1.2     
 avec un halogénure correspondant à la formule :
EMI1.3     

 Les produits de départ, les a,   a diphényl-a-alcoyl-    carbinols ainsi qu, e les dérivés de la   pipérazine    peuvent être obtenus selon des méthodes connues.



   Comme agent de condensation alcalin, on peut utiliser, par exemple,   l'amidure    de sodium, l'hydrure de lithium, etc.



   Suivant le mode opératoire, on obtient les   nou-    veaux composés sous forme de leurs   sets ou de leurs    bases. A partir de ces dernières, on peut, par   réac-    tion sur des acides. appropriés, obtenir des sels, par exemple des hydracides halogènes, des acides sulurique,   phosphorique, maléique, etc.,    ou des acides thérapeutiquement actifs.



   L'examen pharmacodynamique montre que ces nouveaux composés possèdent une bonne activité antiulcéreuse dans le test t de   Shay,    ainsi que sur des ulcères provoqués par la cortisone ou par une com  binaison    de sérotonine, et de réserpine. Les composés sont actifs par voie sous-cutanée ou   per    os à des doses variant de 25-50   mg/kg.   



  Exemple   1    :
 Synthèse du   l- [2- (a-o-cnlorophényl-ap ! hényl-a-    méthyl-carbohydryloxy)-éthyl]-4-benzyl-pipérazine :
 A une   suspension de 12 g d'amidure    de sodium dans 300 ml de toluène absolu, on ajoute lentement 72 g de   α-o-chlorophényl-α-phényl-α-méthyl    carbinol et on chauffe le mélange pendant une heure à 100  C sous forte agitation, on introduit ensuite 55 g de   l-benzyl-442'-chloroéthyl) pipérazine et on co, ntinue    l'agitation pendant 18 heures à 100  C. A la fin de l'opération, l'excès de NaNH2 est détruit par addition d'eau. La solution   toluénique    est ensuite lavée avec 200 ml d'eau et séchée au sulfate de sodium anhydre.

   Après évaporation du toluène, on fractionne le résidu au vide poussé. On   ob. tient    31, 2 g de   1- [2' (a-o-chlorophényl-a-phényl-a-mthyl-carbohy-      dryloxy)-éthyl]-4. benzyl., pipérazine    qui distille à   197-222     C à une pression de 0, 04 mm Hg. Le dichlorhydrate correspondant a été obtenu en   introdui-    sant la quantité théorique de H Cl sec dans une solution   éthérique    de la base libre. On recristallise le produit dans de   l'éthanol    absolu. P. F.   215-217  C.   



  Exemple 2 :
 Synthèse du   1- [2' (a-o-chlorophényl-a-phényl-a-    tert. butyl-carbohydryloxy)-éthyl]-4-benzyl-pipérazine :
 A une suspension de   2,    5   g    d'amidure de sodium suspendu dans 125 ml de toluène sec, on ajoute lentement 17, 2 g de   a-phényl-a-o-chlorophényl-a-    tort.   butyl-carbinol    et on chauffe pendant une heure à   100 C.    On ajoute ensuite 15, 0 g de   1-benzyl-4-      (2'-dhloréthyl)-pipérazin, e    et on chauffe le mélange pendant dix-huit heures à 100  C. A la fin de l'opération, on ajoute 100 ml d'eau, sous agitation.

   On sépare la phase   toluénique    et on la sèche   sur Na2$04-   
Après évaporation du solvant, on fractionne le résidu au vide poussé. On obtient 14, 2 g de   1-[2'-       (α-o-chlorophényl-α-phényl-α-tert.butyl-carbohydryl-      oxy)-éthyl]-4-benzyl-pipérazuie, qui distille à    215  2330    C à une pression de 0, 06 mm Hg.



   Le didhlothydrate correspondant est obtenu en dissolvant la base libre dans la quantité théorique de   HC1    éthanolique et en précipitant le produit avec de l'éther absolu. P. F.   225-2500 C.   



  Exemple 3 :
 Synthèse du   1-[2'-plhényl-a-oshlorophényl-a-      isopropyl-carbohydryloxy)-éthyl]-4-benzyl-pipérazine    :
 A une suspension de 4, 5 g   d'anùdure    de sodium dans   120 ml de toluène    absolu, on ajoute 30 g de   a.-phényl-a-o-chlorophényl-a-isopropylmcarbinol    et on chauffe le mélange pendant une heure à   100     C sous forte agitation. On introduit ensuite 20 g de   1-benzyl-4-    (2'-chloroéthyl) pipérazine et on continue l'agitation pendant dix-huit heures à 100  C. A la fin de l'opération, on lave la   solution toluénique avec    80 ml d'eau et on l'a   sèche sur NaSSO4 anlhydre.

   Après éva-    poration du solvant, on fractionne le résidu au vide poussé. On obtient 15, 0   g    de   1-[2'(a-phényl-a-o-      
 chlorophényl-a-isopropyl-carbohydryloxy)-ethyl]-4-    benzyl-pipérazine qui   distille à 224-238 C à 0, 02mm   
Hg. Le   dichlorhydrate    correspondant est obtenu en traitant la base libre dissoute dans de l'éther sec avec la quantité théorique de   HC1    sec, P. F. i 196  198     C (de   comp.).   




  



  Manufacturing process for new piperazine derivatives
 The present invention relates to a process for the manufacture of new derivatives of the. piperazine, corresponding to the formula:
EMI1.1
 in which R and R ′ ′ represent an alkyl, aralkyl or cyclo-alkyl group containing 1 to 8 carbon atoms, R "representing a halogen atom in the ortho position.



   This process is characterized by the fact that one reacts in the presence of an alkaline condensing agent, a carbinol of the formula
EMI1.2
 with a halide corresponding to the formula:
EMI1.3

 The starting materials, the a, a diphenyl-a-alkylcarbinols as well as the piperazine derivatives can be obtained according to known methods.



   As the alkaline condensing agent, there can be used, for example, sodium amide, lithium hydride, etc.



   Depending on the procedure, the new compounds are obtained in the form of their sets or their bases. From the latter, it is possible, by reaction with acids. suitable salts, for example halogenated hydracids, sulfuric, phosphoric, maleic acids, etc., or therapeutically active acids.



   Pharmacodynamic examination shows that these new compounds have good antiulcer activity in Shay's t test, as well as on ulcers caused by cortisone or by a combination of serotonin and reserpine. The compounds are active by the subcutaneous or oral route at doses varying from 25-50 mg / kg.



  Example 1:
 Synthesis of 1- [2- (a-o-chlorophenyl-ap! Henyl-a-methyl-carbohydryloxy) -ethyl] -4-benzyl-piperazine:
 To a suspension of 12 g of sodium amide in 300 ml of absolute toluene, 72 g of α -o-chlorophenyl- α -phenyl- α -methyl carbinol are slowly added and the mixture is heated for one hour at 100 ° C. with vigorous stirring, 55 g of 1-benzyl-442'-chloroethyl) piperazine are then introduced and stirring is continued for 18 hours at 100 C. At the end of the operation, the excess of NaNH2 is destroyed by adding water. The toluene solution is then washed with 200 ml of water and dried over anhydrous sodium sulfate.

   After evaporation of the toluene, the residue is fractionated in a high vacuum. We ob. holds 31.2 g of 1- [2 '(a-o-chlorophenyl-a-phenyl-a-mthyl-carbohy-dryloxy) -ethyl] -4. benzyl., piperazine which distils at 197-222 ° C. at a pressure of 0.04 mm Hg. The corresponding dihydrochloride was obtained by introducing the theoretical amount of dry HCl into an ethereal solution of the free base. The product is recrystallized from absolute ethanol. P. F. 215-217 C.



  Example 2:
 Synthesis of 1- [2 '(a-o-chlorophenyl-a-phenyl-a-tert. Butyl-carbohydryloxy) -ethyl] -4-benzyl-piperazine:
 To a suspension of 2.5 g of sodium amide suspended in 125 ml of dry toluene, 17.2 g of a-phenyl-a-o-chlorophenyl-a-tort is slowly added. butyl-carbinol and heated for one hour at 100 C. Then 15.0 g of 1-benzyl-4- (2'-dhlorethyl) -piperazin are added, and the mixture is heated for eighteen hours at 100 C. At the end of the operation, 100 ml of water are added, with stirring.

   The toluene phase is separated and dried over Na2 $ 04-
After evaporation of the solvent, the residue is fractionated in a high vacuum. 14.2 g of 1- [2'- (α -o-chlorophenyl- α -phenyl- α -tert.butyl-carbohydryl-oxy) -ethyl] -4-benzyl-pipérazuie are obtained, which distills at 215 2330 C at a pressure of 0.06 mm Hg.



   The corresponding didhlothydrate is obtained by dissolving the free base in the theoretical amount of ethanolic HCl and precipitating the product with absolute ether. P. F. 225-2500 C.



  Example 3:
 Synthesis of 1- [2'-plhenyl-a-oshlorophenyl-a-isopropyl-carbohydryloxy) -ethyl] -4-benzyl-piperazine:
 To a suspension of 4.5 g of sodium anide in 120 ml of absolute toluene, 30 g of a.-phenyl-ao-chlorophenyl-a-isopropylmcarbinol are added and the mixture is heated for one hour at 100 ° C. under high pressure. restlessness. Then 20 g of 1-benzyl-4- (2'-chloroethyl) piperazine are introduced and stirring is continued for eighteen hours at 100 C. At the end of the operation, the toluene solution is washed with 80 ml. of water and dried over anhydrous NaSSO4.

   After evaporation of the solvent, the residue is fractionated under high vacuum. 15.0 g of 1- [2 '(a-phenyl-a-o-
 chlorophenyl-a-isopropyl-carbohydryloxy) -ethyl] -4- benzyl-piperazine which distils at 224-238 C at 0, 02mm
Hg. The corresponding dihydrochloride is obtained by treating the free base dissolved in dry ether with the theoretical amount of dry HCl, mp. 196,198 C (comp.).


 

Claims (1)

REVENDICATION Procédé de fabrication de nouveaux dérivés de la pipérazine de la formule : EMI2.1 dans laquelle R et R'représentent un groupe alcoyle, aralcoyle ou cyclo-alooyle, contenant 1 à 8 atomes de carbone, R" représentant un atome d'halogène en position ortho, caractérisé par le fait que l'on fait réagir en présence d'un agent de condensation alca- lin un carbinol de la formule : EMI2.2 avec un halogénure correspondant à la formule EMI2.3 SOUS-REVENDICATIONS 1. CLAIM Manufacturing process for new piperazine derivatives of the formula: EMI2.1 in which R and R ′ represent an alkyl, aralkyl or cyclo-alooyl group, containing 1 to 8 carbon atoms, R "representing a halogen atom in the ortho position, characterized in that one reacts in the presence of an alkaline-carbinol condensing agent of the formula: EMI2.2 with a halide corresponding to the formula EMI2.3 SUB-CLAIMS 1. Procédé selon la revendication, caractérisé par le fait que ledit oarbinol est le a-o-cilorophényl-a- phényl-&alpha;-méthyl-carbinol, ledit halogénure étant le lbenzyl-4-(2-oMoroéthyl)-pipérazine. Process according to Claim, characterized in that the said oarbinol is a-o-cilorophenyl-a-phenyl- &alpha; -methyl-carbinol, the said halide being lbenzyl-4- (2-oMoroethyl) -piperazine. 2. Procédé selon la revendication, caractérisé par le fait que ledit carbinol est le &alpha;-phényl-&alpha;-o-chloro- phényl-&alpha; tert. butyl-carbinol, ledit halogénure étant le lHbenzyl-4-(2'-ohloroéthyl) < pipérazine. 2. Method according to claim, characterized in that said carbinol is &alpha; -phenyl- &alpha; -o-chloro-phenyl- &alpha; tert. butyl-carbinol, said halide being 1Hbenzyl-4- (2'-ohloroethyl) <piperazine. 3. Procédé selon la revendication, oaractérisé par le fait que ledit carbinol est le a-phényl-a-o-chloro- phényl-a-isopropyl-carbinol, ledit halogénure étant le l-benzyl-4 (2' < hloroéthyl) ; pipérazine. 3. Method according to claim, oaracterized in that said carbinol is α-phenyl-α-o-chloro-phenyl-α-isopropyl-carbinol, said halide being 1-benzyl-4 (2 '<hloroethyl); piperazine. 4. Procédé selon la revendication, caractérisé par le fait que ledit agent de condensation alcalin est l'amidure de sodium. 4. Method according to claim, characterized in that said alkaline condensing agent is sodium amide. 5. Procédé selon la revendication, caractérisé par le fait que ledit agent de condensation est l'hydrure de lithium. 5. Method according to claim, characterized in that said condensing agent is lithium hydride. 6. Procédé selon la revendication, caractérisé par le fait que les bases obtenues sont transformées en sels. 6. Method according to claim, characterized in that the bases obtained are converted into salts.
CH683561A 1961-06-12 1961-06-12 Manufacturing process for new piperazine derivatives CH396007A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CH683561A CH396007A (en) 1961-06-12 1961-06-12 Manufacturing process for new piperazine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH683561A CH396007A (en) 1961-06-12 1961-06-12 Manufacturing process for new piperazine derivatives

Publications (1)

Publication Number Publication Date
CH396007A true CH396007A (en) 1965-07-31

Family

ID=4315767

Family Applications (1)

Application Number Title Priority Date Filing Date
CH683561A CH396007A (en) 1961-06-12 1961-06-12 Manufacturing process for new piperazine derivatives

Country Status (1)

Country Link
CH (1) CH396007A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4866062A (en) * 1986-04-28 1989-09-12 Richter Gedeon Vegyeszeti Gyar 1,4-disubstituted piperazines, pharmaceutical compositions thereof and method of use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4866062A (en) * 1986-04-28 1989-09-12 Richter Gedeon Vegyeszeti Gyar 1,4-disubstituted piperazines, pharmaceutical compositions thereof and method of use

Similar Documents

Publication Publication Date Title
CH375017A (en) Process for the preparation of novel imidazole derivatives
EP0002978B1 (en) Thiazolidinedione-2,4 derivatives, their preparation and pharmaceutical applications
EP0301936B1 (en) Piperidine derivatives, their preparation and their therapeutical use
CH407088A (en) Process for the preparation of 4-halo-3-sulfamoyl-benzoic acid derivatives
FR2521140A1 (en) IMIDAZOLIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2637596A1 (en) METHYL-4 ((ARYL-4-PIPERAZINYL-1) -2-ETHYL) -5 THIAZOLE AND ITS DERIVATIVES, PROCESS FOR PREPARING THEM AND MEDICAMENTS CONTAINING THE SAME
CH396007A (en) Manufacturing process for new piperazine derivatives
EP0037777B1 (en) Process for preparation of cycloalcoyl propanol amines useful as medicine
CH407087A (en) Process for the preparation of new derivatives of diphenylacetamide
FR2597867A1 (en) SUBSTITUTED ETHANEDIIMIDAMIDES
EP0067094A1 (en) Heterocyclic derivatives of amidoximes, their preparation and therapeutic uses
EP0625514B1 (en) 2-Amino-pyrazin-5-carboxamid derivatives, their preparation and their use in therapy
CH587796A5 (en) 2-Aminoalkyl amino indanes - anti-arrhythmic,orally active, long-acting, not myocardial depressant
CH587795A5 (en) 2-Aminoalkyl amino indanes - anti-arrhythmic,orally active, long-acting, not myocardial depressant
FR2496661A1 (en) 1,4-SUBSTITUTE DERIVATIVES OF PIPERAZINE, THEIR PREPARATION AND DRUG CONTAINING THESE SUBSTANCES
CH420107A (en) Process for the preparation of new substituted aralkylaminoalkylcyclohexane derivatives
CH332334A (en) Manufacturing process of N-benzhydryl-N&#39;-benzylpiperazines
CH332664A (en) Process for preparing N-benzhydryl-N&#39;-benzylpiperazines
CH617696A5 (en) Process for the preparation of new derivatives of isoindoline
CH346221A (en) Process for the preparation of piperazine derivatives
CH500945A (en) Alpha-%aminoalkoxyphenyl-alpha-nitrostilbenes anti
CH301246A (en) Process for the preparation of a new chemical compound having antispasmodic activity.
CH354084A (en) Method for preparing piperazines
CH501595A (en) 2-phenoxy-2-phenylacetamides
CH376491A (en) Process for the preparation of substituted triphenylethylenes